Skip to main content
Top
Published in: Respiratory Research 1/2022

Open Access 01-12-2022 | Pneumothorax | Letter to the Editor

Pneumothorax management: current state of practice in the UK

Authors: Rob J. Hallifax, Mark Roberts, Nicky Russell, Magda Laskawiec-Szkonter, Steve P. Walker, Nick A. Maskell, Najib M. Rahman

Published in: Respiratory Research | Issue 1/2022

Login to get access

Abstract

Background and objective

Spontaneous pneumothorax is a common pathology but optimal initial treatment regime is not well defined. Treatment options including conservative management, needle aspiration (NA) or insertion of a small-bore chest drain. Recent large randomised controlled trials may change the treatment paradigm: comparing conservative and ambulatory management to standard care, but current guidelines need to be updated. The aim of this study was to assess the current “state of play” in the management of pneumothorax in the UK.

Methods

Physicians and respiratory healthcare staff were invited to complete an online survey on the initial and subsequent management of pneumothorax.

Results

This study is the first survey of pneumothorax practice across the UK, which highlights variation in practice: 50% would manage a large primary pneumothorax with minimal symptoms conservatively, compared to only 3% if there were significant symptoms; 64% use suction if the pneumothorax had not resolved after > 2 days, 15% always clamp the chest drain prior to removal; whereas 30% never do. NICE guidance recommends the use of digital suction but this has not translated into widespread usage: only 23% use digital suction to check for resolution of air leak).

Conclusion

Whilst there has always been allowance for individual clinician preference in guidelines, there needs to be consensus on the optimum management strategy. The challenge the new guidelines face is to design a simple and pragmatic approach, using this new evidence base.
Literature
1.
go back to reference Hallifax RJ, Goldacre R, Landray MJ, et al. Trends in the incidence and recurrence of inpatient-treated spontaneous pneumothorax, 1968–2016. JAMA. 2018;320(14):1471–80.CrossRef Hallifax RJ, Goldacre R, Landray MJ, et al. Trends in the incidence and recurrence of inpatient-treated spontaneous pneumothorax, 1968–2016. JAMA. 2018;320(14):1471–80.CrossRef
2.
go back to reference Bobbio A, Dechartres A, Bouam S, et al. Epidemiology of spontaneous pneumothorax: gender-related differences. Thorax. 2015;70(7):653–8.CrossRef Bobbio A, Dechartres A, Bouam S, et al. Epidemiology of spontaneous pneumothorax: gender-related differences. Thorax. 2015;70(7):653–8.CrossRef
3.
go back to reference Tschopp JM, Bintcliffe O, Astoul P, et al. ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax. Eur Respir J. 2015;46(2):321–35.CrossRef Tschopp JM, Bintcliffe O, Astoul P, et al. ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax. Eur Respir J. 2015;46(2):321–35.CrossRef
4.
go back to reference MacDuff A, Arnold A, Harvey J. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii18-31.CrossRef MacDuff A, Arnold A, Harvey J. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii18-31.CrossRef
5.
go back to reference Brown SGA, Ball EL, Perrin K, et al. Conservative versus interventional treatment for spontaneous pneumothorax. N Engl J Med. 2020;382(5):405–15.CrossRef Brown SGA, Ball EL, Perrin K, et al. Conservative versus interventional treatment for spontaneous pneumothorax. N Engl J Med. 2020;382(5):405–15.CrossRef
6.
go back to reference Hallifax RJ, McKeown E, Sivakumar P, et al. Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial. Lancet. 2020;396(10243):39–49.CrossRef Hallifax RJ, McKeown E, Sivakumar P, et al. Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial. Lancet. 2020;396(10243):39–49.CrossRef
7.
go back to reference Yeoh JH, Ansari S, Campbell IA. Management of spontaneous pneumothorax—a Welsh survey. Postgrad Med J. 2000;76:496–9.CrossRef Yeoh JH, Ansari S, Campbell IA. Management of spontaneous pneumothorax—a Welsh survey. Postgrad Med J. 2000;76:496–9.CrossRef
9.
go back to reference Hallifax RJ, Laskawiec-Szkonter M, Rahman NM. Predicting outcomes in primary spontaneous pneumothorax using air leak measurements. Thorax. 2019;74(4):410–2.PubMed Hallifax RJ, Laskawiec-Szkonter M, Rahman NM. Predicting outcomes in primary spontaneous pneumothorax using air leak measurements. Thorax. 2019;74(4):410–2.PubMed
Metadata
Title
Pneumothorax management: current state of practice in the UK
Authors
Rob J. Hallifax
Mark Roberts
Nicky Russell
Magda Laskawiec-Szkonter
Steve P. Walker
Nick A. Maskell
Najib M. Rahman
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-022-01943-9

Other articles of this Issue 1/2022

Respiratory Research 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.